Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke

INTRODUCTION: Alteplase is widely used as an intravenous thrombolytic drug in acute ischemic stroke (AIS). Recently however, tenecteplase, a modified form of tissue plasminogen activator, has been shown to increase early recanalization rate and has proven to be non-inferior with a similar safety pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Chi Phuong, Lahr, Maarten MH, van der Zee, Durk-Jouke, van Voorst, Henk, Roos, Yvo BWEM, Uyttenboogaart, Maarten, Buskens, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472948/
https://www.ncbi.nlm.nih.gov/pubmed/37641549
http://dx.doi.org/10.1177/23969873231174943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472948/
https://www.ncbi.nlm.nih.gov/pubmed/37641549
http://dx.doi.org/10.1177/23969873231174943

Ejemplares similares